Kliniske undersøgelser viser, at behandlingen af de fleste patienter forløber godt, hvis blodkoncentrationerne holdes under 20 ng/ ml.
Clinical study analysis suggests that the majority of patients can be successfully managed if tacrolimus blood trough levels are maintained below 20 ng/ ml.